CUME Subsidy: Care of Minors Affected by Cancer or Another Serious Illness
The financial benefit for caring for minors affected by cancer or another serious illness (CUME) is a state subsidy intended to compensate for the loss of income of working parents who reduce their working hours (at least by 50%) for the direct, continuous and permanent care of the minor in their care.
Key Aspects and Relevance for Neuropediatric Consultation
The neuropediatrician of the Public Health Service plays a determining role in issuing the mandatory clinical report. The critical points of practical interest are:
- Continuing Care Criteria: Medical certification that the minor requires direct, permanent and continuous care from his or her parents due to the severity of the clinical condition or the need for constant hospital/home care.
- List of Neurological Pathologies Included (Annex RD 1148/2011 and Order TMS/103/2019):
- Encephalopathies and metabolic diseases with progressive neurological involvement.
- Degenerative neuromuscular diseases and spinal muscular atrophies.
- Infantile cerebral palsy with great functional dependency.
- Severe refractory epilepsies of infants and children (complex epileptic syndromes).
- Acquired brain damage, severe traumatic brain injuries and pediatric stroke in the intensive rehabilitation phase.
- Extension of Coverage: The benefit can be extended until age 23 (or 26 years if there is a proven disability equal to or greater than 65%), as long as the need for permanent care persists.
Official Document and Complete List of Diseases (BOE)
Official Legal Reference
Official Publication: Spain. Ministry of Labor, Migration and Social Security. Order TMS/103/2019, of February 6, which modifies the annex to Royal Decree 1148/2011, of July 29, for the application and development, in the Social Security system, of the economic benefit for the care of minors affected by cancer or another serious illness. Official State Gazette (BOE), February 8, 2019, no. 34, pages 11724 to 11731 (Ref. BOE-A-2019-1691).
